Dr Ashish Srivastava

Dr. Ashish Srivastava is an Professor in the Department of Pharmaceutical chemistry, Pranveer Singh Institute of Technology, Pharmacy ,Kanpur. Graduate aptitude test of Engineering fellowship was awarded to him in 2006. He has 16 years of teaching experience and research experience in various fields. His field of research mainly includes the synthesis of antidiabetic, anti-inflammatory compounds, and bone targeting prodrugs. He has published a number of research papers in scientific journals. He has participated and delivered lectures at various National and International Symposia. He is also a member of several professional societies. Until now over ten students have completed their M.Pharm. degree under his guidance. He is the author of several stimulating books on organic and Medicinal chemistry.

EDUCATION

Ph.D. in Pharmaceutical Chemistry, 2013-2021, AKTU, Lucknow
M.Pharm. in Pharmaceutical Chemistry, 2006-2008, Meerut Institute of Engineering and Technology, Meerut
B.Pharm. with 70%, 2002-2006, Pharmacy College Azamgarh
B.Sc. with 63%, 2000-2002, CSJMU Kanpur
12th with 64%, 1999, B.N.S.D. Inter College Kanpur
10th with 60%, 1997, B.N.S.D. Inter College Kanpur

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacy, Pharmacology, Toxicology and Pharmaceutics, Drug Discovery, Organic Chemistry

Scopus Publications

Design, classification, and adverse effects of NSAIDs: A review on recent advancements
Minhajul Arfeen, Ashish Srivastava, Noopur Srivastava, Riaz A. Khan, Suliman A. Almahmoud, and Hamdoon A. Mohammed
Elsevier BV



Low temperature auto-flame fabricated LiMn<inf>1.5</inf>Ni<inf>0.5</inf>O<inf>4</inf> materials as spinel electrode for supercapacitor
Laxman Singh, Sunil Kumar, Saravana Kumar Balakrishnan, Atendra Kumar, Anees A. Ansari, Akhilesh Kumar, Abhishek Rai, Ashish Kumar Srivastava, Avinash Kumar Sonkar, and Youngil Lee
Springer Science and Business Media LLC



The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review
Ankita Wal, Ashish Srivastava, Neha Verma, Shiv Shanker Pandey, and Sachin Tyagi
Bentham Science Publishers Ltd.
Background: Irritable bowel syndrome (IBS) is a prolonged bowel illness that is general-ly stress-related and is characterized by a variety of gastrointestinal problems, the most prominent of which is chronic visceral abdominal discomfort. As a result, IBS typically impacts sufferers' standard of living, and it is typically associated with depression and anxiety symptoms. IBS medica-tion is based mostly on symptom alleviation. However, no effective medicines have been discov-ered too far. As a result, it is essential to discover novel anti-IBS medications. Objective: The purpose of this brief review is to describe the existing research on nutraceutical sup-plements in irritable bowel syndrome management, including probiotics, prebiotics, symbiotics, herbal products, and dietary fibers. Methods: This review covered the relevant papers from the previous twenty years that were availa-ble in different journals such as Science Direct, Elsevier, NCBI, and Web of Science that were re-lated to the role and function of Nutraceuticals in Irritable Bowel Syndrome. Results: Neutraceutical substances have a variety of modes of action, including restoring the healthy microbiome, improving the function of the gastrointestinal barrier, immunomodulatory, an-ti-inflammatory, and antinociceptive properties. According to the literature, these substances not on-ly can improve irritable bowel syndrome symptomatology but also have an excellent long-term safety profile. Conclusion: Irritable bowel syndrome is a prolonged bowel illness with a lot of gastrointestinal problems. The nutraceuticals treatment works as an anti-IBS intervention and enhances patient compliance with minimum side effects since patients take it better than pharmaceutical treatments.


Spectroscopic and electrochemical investigation of mixed – ligand transition metal complexes with 2N-salicylidine-5-(p-nitrophenyl)-1, 3, 4-thiadiazole and 5, 5’-Me<inf>2</inf>bipy in aqueous medium
Ashish Kumar Srivastava and Archana Rai
World Researchers Associations
Herein we reported the spectroscopic and electrochemical investigation of four transition metal complexes viz. VO(II), Co(II), Ni(II) and Cu(II) of 2N-salicylidine-5-(p-nitrophenyl)-1, 3, 4-thiadiazole Schiff base ligand (L) and 5,5’-dimethyl-2,2’-bipyridine (Me2bipy) in the aqueous (1: 1: 1 molar ratio) medium. Transition metal complexes were characterized by microanalysis, FT-IR, electronic absorption and mass spectroscopy. Electrochemistry of transition metal complexes was studied in aqueous medium by using cyclic voltammetry (CV) at glassy carbon working electrode (GCE) versus Ag/AgCl. The reduction potential of the VO (II) and Cu (II) becomes more negative with increasing scan rate while Co (II) and Ni (II) positive show easier reduction.


Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments
Ankita Wal, Pranay Wal, Himangi Vig, Nem Kumar Jain, Shruti Rathore, Karthickeyan Krishnan, and Ashish Srivastava
Bentham Science Publishers Ltd.
Background: Parkinson’s disease (PD) is a neurodegenerative syndrome defined by a variety of motor, cognitive, and psychomotor dysfunctions. The current pharmaceutical treatment focuses on treating the condition's symptoms. They are primarily concerned with reducing illness symptoms or avoiding dopamine metabolism. As our understanding of disease pathogenesis improves, new therapeutic approaches emerge. Objective: This article aims to describe the standard Parkinson's medications based on symptoms and requirements. It emphasizes recent advancements in symptomatic therapy for motor indications and achievements in the research and clinical testing of medicines that promise to enable disease modification in patients with already-manifest PD. Methods: Information for this paper was found by looking through Google Scholar and reading several research and review articles from Bentham Science, Science Direct, Elsevier, Frontiers, Taylor &amp; Francis, and other publishers. Result: Parkinson's disease therapeutic interventions are now limited to symptomatic therapy, mostly in dopaminergic medications and deep brain stimulation (DBS). They have the potential to deliver great therapeutic progress, yet they can also have serious drawbacks that decrease a patient's quality of life. The progress of pluripotent stem cell therapies and genome engineering procedures has sparked renewed hope for the treatment of a wide range of human illnesses, particularly genetic abnormalities. Conclusion: The current Parkinson's therapy trends are successful and continually evolving, with several drugs currently undergoing clinical trials. As these new therapies constantly coming out and can be used together, they will likely change how Parkinson's disease is treated in the coming years.


Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
Ankita Wal, Pranay Wal, Himangi Vig, Shruti Rathore, Shiv Shanker Pandey, Nem Kumar Jain, and Ashish Srivastava
Bentham Science Publishers Ltd.
Background: Parkinson's disease is a complicated, gradually progressive neurological illness characterized by locomotor and non-motor symptomatology that impedes daily activities. Despite significant advances in symptomatic therapies with various extents of negative effects, there are currently no disease-modifying medicinal alternatives. Symptoms worsen, creating an additional strain that reduces living quality and creates the perception that prescription drugs are no longer productive. Objective: Adopting healthy lifestyle habits can help patients feel more empowered, promote wellness, relieve symptoms, and potentially slow neurodegeneration. Nutrition, intellectual stimulation, physical exercise, and stress reduction are all examples of lifestyle habits that improve cognitive health and life satisfaction. We discuss how changes in lifestyle, nutrition, yoga, exercise, and acupuncture can help with managing the disease's symptoms. Methods: We searched Google Scholar for various research papers and review articles from publishers, such as Bentham Science, Elsevier, Taylor and Francis, Springer Nature, and others for gathering the data for the study. Results: Pesticide exposure, environmental hazards, dietary choices, stress, and anxiety all have an indirect or immediate influence on the commencement of Parkinson's disease. Naturopathic remedies, such as nutraceuticals, yoga, exercise, and acupuncture, have been shown to help with Parkinson's disease management. Conclusion: Various preclinical and clinical studies have shown that the various factors mentioned are beneficial in the management of the disease, but more research is needed to validate the extent to which such factors are beneficial.


Synthesis, characterization, biological (in vitro) activity, spectral and electrochemical behavior of N, S donors Schiff base ligand and their mixed-ligand copper (II)/cobalt (II) complexes with 5, 5’-dimethyl-2, 2’-bipyridine and 1, 10-phenanthroline
Ashish Kumar Srivastava, Krishna Srivastava, and Jagdish Prasad
World Researchers Associations
Herein we reported the synthesis of (E)-N-(4- (thiophen-2-ylmethyleneamino) phenylsulfonyl) acetamide Schiff base ligand in an ethanolic medium. The Schiff base was derived from sulfaacetamide (N [4- (amino-phenyl)sulfonyl]acetamide) and 2- thiophenecarboxaldehyde and their mixed ligand copper(II)/cobalt(II) complexes (viz [Co(L)(5,5’- Me2bipy)(H2O)Cl]Cl, 1: [Co(L)(1,10-phen)(H2O)Cl] Cl, 2: [Cu(L)(5,5’-Me2bipy)(H2O)2], 3: and [Cu(L) (1,10-phen)(H2O)2] and 4: aromatic diimines (viz; 5,5’-dimethyl-2,2’-bipyridine, 1,10-phenanthroline) were prepared in 1:1:1 molar ratios and have been characterized by using different physico- chemical techniques. The investigation includes microanalysis, melting point, molar conductance, magnetic susceptibility, FTIR, UV-Visible and mass spectroscopy. Electrochemical and biological (in vitro) activities of Schiff base and their complexes have also been studied.


Phytochemical profiling, molecular docking, and in vitro anti-hepatocellular carcinoid bioactivity of Suaeda vermiculata extracts
Hamdoon A. Mohammed, Suliman A. Almahmoud, Minhajul Arfeen, Ashish Srivastava, Mahmoud Z. El-Readi, Ehab A. Ragab, Safia M. Shehata, Salman A.A. Mohammed, Ehab M. Mostafa, Hend A. El-khawaga,et al.
Elsevier BV



Preparation and Evaluation of Efavirenz Loaded Solid Lipid Nanoparticle for improving Oral Bioavailability
Ashish Srivastava and Harshita Gupta
A and V Publications
Efavirenz (EFV) is a highly lipophilic, oral non-nucleoside reverse transcriptase inhibitor reported to have poor aqueous solubility and bioavailability used for the treatment of HIV. In the present research work, solid lipid nanoparticles loaded with efavirenz were formulated for oral drug delivery and to increase the bioavailability of efavirenz. Solid lipid nanoparticles loaded with efavirenz were prepared through the microemulsion method followed by the lyophilization technique using glyceryl monostearate as lipid and Tween 80 as a surfactant. Solid lipid nanoparticle formulation was evaluated using different parameters including Scanning electron microscopy (SEM), drug entrapment efficiency (EE%), in vitro drug release study, differential scanning calorimetry, and powder X-ray diffractometry. Solid lipid nanoparticles loaded efavirenz showed 60.41% drug entrapment. Differential scanning calorimetry and powder X-ray diffractometry study indicate solid lipid nanoparticles loaded efavirenz is crystalline, stable and there is no interaction between the excipients and drug. In vitro drug release study of EFV-SLN showed 88.2±0.12% drug release which is better as compared to marketed formulation drug release. EFV-SLN drug release study data demonstrated a better fit for the first-order kinetics and confirmed the non-Fickian-diffusion mechanism. Prepared SLN formulation has shown good stability at 45∘C and 75% relative humidity (RH) for 150 days. These results determined that the developed EFV-SLN formulation exhibited a promising antiviral activity to treat HIV and has great potential for boosting the oral bioavailability of Efavirenz.


Electrochemical and spectral investigation of copper (II) complexes with various hydroxynicotinic acids in dimethylsulfoxide
Ashish Kumar Srivastava
Elsevier BV



Design and Evaluation of Efavirenz Loaded Solid Lipid Nanoparticle for Boosting Oral Bioavailability
Harshita Gupta and Ashish Srivastava
BSP Books Private Limited
Present work illustrates that efavirenz-loaded solid lipid nanoparticles were prepared with the objective of increasing bioavailability and protection of drugs due to biocompatible lipidic content. Efavirenz is generally used for the treatment of HIV. Selection of the suitable lipid phase, surfactant, and cosurfactant was done by individual screening method with the construction of pseudo-ternary phase study. The formulations were prepared by the microemulsion method followed by the lyophilization technique. EFV-SLN has shown a mean particle size of 55.73 ± 3.9 nm having a PDI of 0.153 ± 0.451. Zeta potential was found to be -9.98mV and the formulation was found stable. In vivo pharmaco-kinetic studies exhibited 5.41-fold enhancement in peak plasma concentration (


Synthesis, characterization and fluorescence properties of mixed-ligand cobalt(II), copper(II), zinc(II) and cadmium(II) coordination polymer complexes involving 4,4'-bipyridine and 2,5-pyridinedicarboxylic acid




Synthesis, characterization, biological and electrochemical investigation of copper (II) complexes containing 4-chloro-2-[2, 6-diisopropylphenylimino) methyl] phenol Schiff base ligand and aromatic diinines
Ashish Kumar Srivastava, Prem Yadav, Krishna Srivastava, and Jagdish Prasad
Elsevier BV



Synthesis, characterization, biological (in vitro) activity and electrochemical studies of mixed-ligand copper (II) and cobalt (II) complexes with picolinic acid and imides
Ashish Kumar Srivastava, Krishna Srivastava, Prem Yadav, Jagdish Prasad, and Ajeet Kumar Maurya
Elsevier BV



Electrochemical and spectral studies of binary and mixed-ligand copper(II) and cobalt(II) complexes with 2,6-dipicolinic acid and bathophenanthroline chelating ligand in aqueous medium
Ashish Kumar Srivastava, Krishna Srivastava, and Jagdish Prasad
Elsevier BV



Spectral, biological antimicrobial activity (in vitro) and effect of solvents on the electrochemical behavior of four newly synthesized copper(II) complexes with 4-hydroxynicotinic acid containing 2,2′-bipyridine/5,5′-Me<inf>2</inf>-bipy/1,10-phenanthroline/DMP
Ashish Kumar Srivastava, Sandeep Kumar Singh, and Alka Srivastava
Elsevier BV



Nsaids-alendronate based prodrug for bone specific drug targeting
Ashish Srivastava, Ashutosh Mishra, and A. K. Rai
A and V Publications



Synthesis, characterization and evaluation of ulcerogenic potential for NSAIDs-alendronate based prodrug
Ashish Srivastava, Ashutosh Mishra, and A. K. Rai
A and V Publications



Synthesis, characterization, spectroscopic and electrochemical investigation of 2-aminopyridine-3-carboxylic acid copper(II) complexes with diimine
Ashish Kumar Srivastava, Krishna Srivastava, and Jagdish Prasad
Elsevier BV



Therapeutic potential of prodrugs towards targeted drug delivery
Abhinav P. Mishra, Suresh Chandra, Ruchi Tiwari, Ashish Srivastava, and Gaurav Tiwari
Bentham Science Publishers Ltd.
In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome various undesirable drug properties. There are certain techniques which are used for tumor targeting such as Antibody Directed Enzyme Prodrug Therapy [ADEPT] Gene-Directed Enzyme Prodrug Therapy [GDEPT], Virus Directed Enzyme Prodrug Therapy [VDEPT] and Gene Prodrug Activation Therapy [GPAT]. Our review focuses on the Prodrugs used in site-specific drug delivery system specially on tumor targeting.


Seed priming with salts of nitrate enhances nitrogen use efficiency in rice
Ashish Kumar Srivastava, Anaytullah Siddique, Manoj Kumar Sharma, and Bandana Bose
Springer Science and Business Media LLC
An experiment was conducted to investigate the absorption and utilization of nitrogen by rice seed treatment with Nitrate salts (halo priming) and distilled water (hydro-priming) in two successive years. Results revealed that seed priming with Mg (NO3)2, KNO3 and Distilled water always perform better than non-primed control sets in enhancing seed germination and nitrate reductase enzyme activity in leaves that promote to nitrogen accumulation in different plant parts. This seed priming technique further enhanced soluble and insoluble nitrogen content in seed, and also the nitrogen gathering capacity in seed and straw (Kg h-1). Seed priming was also found beneficial in encouraging grain yield after applying Kg-1 nitrogen in the soil. This technique proved promising in more nitrogen accumulation and less nitrogen loss. Among seed priming treatment Mg (NO3)2 performed the best in respect to all measured parameters followed by KNO3 and hydro-primed one in comparison to control sets. These results clearly indicated that higher yield in rice can be achieved via improving the nitrogen absorption and utilization by growing crop, raised with seed priming treatment especially using Mg (NO3)2 salts.


Synthesis, characterization and electrochemical investigations of mixed-ligand copper(II)-organic supramolecular frameworks
Sandeep K. Singh, Ashish Kumar Srivastava, Krishna Srivastava, Rahul Banerjee, and Jagdish Prasad
Elsevier BV



Pyridyl substituted 4-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-ylmethyl)-benzamides with aggregation enhanced emission and multi-stimuli-responsive properties
Ashish Kumar Srivastava, Alok Kumar Singh, Niraj Kumari, Richa Yadav, Antonino Gulino, Adolfo Speghini, Rajamani Nagarajan, and Lallan Mishra
Elsevier BV



Tuning of aggregation enhanced emission and solid state emission from 1,8-naphthalimide derivatives: Nanoaggregates, spectra, and DFT calculations
Ashish Kumar Srivastava, Avinash Singh, and Lallan Mishra
American Chemical Society (ACS)
Four new 1,8-naphthalimide based compounds, 4-(1,3-dioxo-1H,3H-benzo[de]isoquinolin-2-ylmethyl)-benzoic acid (LH), 4-(1,3-dioxo-1H,3H-benzo[de]isoquinolin-2-ylmethyl)-benzoic acid methyl ester (LMe), 4-(1,3-dioxo-1H,3H-benzo[de]isoquinolin-2-ylmethyl)-benzoyl chloride (LCl), and 4-(1,3-dioxo-1H,3H-benzo[de]isoquinolin-2-ylmethyl)-benzoic acid hydrazide (LN) are synthesized and characterized using spectral data and X-ray crystallography. They form nanoaggregates in aqueous-DMF solution and exhibited aggregation enhanced emission. The nanoaggregates are characterized using their scanning electron and atomic force microscopy images. The emission intensity follows the order as LH > LMe > LCl > LN. Their photophysical properties are recorded both in solution and in the solid-state and are correlated with the nature of benzoic acid derivatives owing to the combinatorial effect of π-π stacking and intermolecular and intramolecular interactions. The density functional theory calculations empower the understanding of their molecular and cumulative electronic behaviors. Antiparallel dimeric interactions in the solid-state extend a herringbone arrangement to LH and 2D channel and stair-like arrangement for LCl and LN, respectively.


Rhodamine hydrazone as OFF-ON-OFF type selective sequential sensor of Al³⁺ and N<inf>3</inf>^- ions
Abhishek Rai, Niraj Kumari, Ashish Kumar Srivastava, Sandeep Kumar Singh, Saripella Srikrishna, and Lallan Mishra
Elsevier BV

RECENT SCHOLAR PUBLICATIONS

“Exploring the Potential of Benincasa hispida Sterols and Terpenes as Acetylcholinesterase Inhibitors for Alzheimer's Disease Therapy"
PBAS Parul Srivastava1, Sonal H Vaishnav2, Dr. Annapragada Pratyusha3, Nidhi ...
African Journal of Biological Sciences (South Africa) 6 (14), 9422 of 11 2024



Hydroalcoholic Extract of Terminalia pallida Brandis for its Gastroprotective Effects in Wistar rats
AKY 1Priyanka Verma, 1Ashish Srivastava, 1Parul Srivastava, 1Shashi P. Singh ...
African journal of biological sciences 6 (14), 1738 to 10 2024



Design, classification, and adverse effects of NSAIDs: A review on recent advancements
MAASASNSS all 6 authorsHamdoon A. Mohammed
Bioorganic & Medicinal Chemistry 112, 1-16 2024



"Exploring Benincasa hispida Constituents as Inhibitors of Monoamine Oxidase B: Insights from Molecular Docking"
AS Parul Srivastava, Anil Kumar Yadav, Priyanka Verma, Ramji Mishra ...
African Journal of Biological Sciences 6 (12), 5397 of 10 2024



NOVEL CHALCONE DERIVATIVES AS POTENTIAL ANTIHYPERGLYCEMIC AGENTS: SYNTHESIS AND BIOLOGICAL EVALUATION
PS Sudha Kumari, Ashish Srivastava
African Journal of Biological Sciences (South Africa) 6 (12), 4613-4624 2024



A COMPREHENSIVE ASSESSMENT ON CONVENTIONAL MEDICATIONS AND NUTRITIONAL SUPPLEMENTS AVAILABLE FOR HYPERLIPIDEMIA
AS Aishwarya Bajpai, Ashish Srivastava, Anil K. Yadav
African Journal of Biological Sciences 6 (11), 1043-1061 2024



Evaluation of Antiviral, Antibacterial and Antioxidant Activity of Morinda tinctoria Roxb., Abroma augusta L. Educes and Myristica fragrans Houtt. Ethereal Oil in Microcapsules
AKY Garima Verma1, Priyanka Verma2, Ashish Srivastava2
INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 15 (2), 689-697 2024



PREDICTIVE INSIGHTS INTO THE ADME AND TOXICOLOGICAL PROFILES OF ALLIUM SATIVUM PHYTOCHEMICALS USING SWISS ADME AND PROTOX-I
PDNGRR Manukonda Upender Kumar, Dr Ashish Srivastava , Dr. Anandkumar K ...
African Journal of Biological Sciences 6 (Issue - 6), 488-509 2024



Liposomes as Transformative Tools in Drug Delivery, Therapeutics, and Beyond
AKYAKR Ashish Srivastava*, Anshuman Singh, Parul Srivastava, Ankita Wal ...
Current Drug Therapy 2024



The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review
A Wal, A Srivastava, N Verma, SS Pandey, S Tyagi
Current Pediatric Reviews 20 (1), 66-75 2024



Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
P Wal, H Vig, A Wal, S Rathore, SS Pandey, NK Jain, A Srivastava
Current Aging Science 16 (3), 170-187 2023



Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments
A Wal, P Wal, H Vig, NK Jain, S Rathore, K Krishnan, A Srivastava
Current Drug Discovery Technologies 20 (5), 54-70 2023



A review on Phytosomes, their characterization method, advancement & potential application
AY Ashish Srivastava* , Pranay Wal Versha Chaturvedi , Parul Srivastava ...
YMER 22 (2), 141-187 2023



A Comprehensive Review on Phytoconstituents and Pharmacological Activity of Holy Basil Ocimumsanctum (Tuls
NKSS Anil K. Yadav* , Yash K. Singh, Pranay Wal, Ashish Srivastava, Ankita ...
European Chemical Bulletin 12 (10), 2242-2275 2023



Investigating the Drug Potential of a Natural COX Inhibitor: ADME and In Silico Analysis
PS Ashish Srivastava, Ashutosh Verma ,Ankita Wal, Versha Chaturvedi, Pranay Wal
Journal of Population Therapeutics and Clinical Pharmacology 29 (4), 1326–1342 2022



SUSTAINABILITY IN PHARMACEUTICALS: AN IN-DEPTH LOOK AT THE GREEN PHARMACY PRINCIPLES
PS Parul Srivastava1*, Ankita Wal2,Versha Chaturvedi3,Pranay Wal4 ...
Journal of Population Therapeutics and Clinical Pharmacology 29 (4), 1304–1325 2022



BEYOND BLOOD SUGAR CONTROL: A COMPREHENSIVE REVIEW OF DPP-4 INHIBITORS AND THEIR EXPANDING LANDSCAPE
AS Parul Srivastava, Pranay Wal, Versha Chaturvedi, Ankita Wal
Journal of Population Therapeutics and Clinical Pharmacology 29 (4), 1273–1303. 2022



THE SCIENCE OF HOPE: A COMPREHENSIVE REVIEW OF COVID-19 VACCINE PROGRESS
AY Ashish Srivastava, Versha Chaturvedi ,Pranay Wal, Parul Srivastava ...
Journal of Population Therapeutics and Clinical Pharmacology 29 (4), 1359–1390 2022



A Comprehensive Review on Monkeypox Virus Transmission, Pathogenesis, Treatments and its Preventive Measures
ZN Anil K. Yadav , Ashish Srivastava , Priyanka Verma , Parul Srivastava ...
NeuroQuantology 20 (10), 7320-7335 2022



Phytochemical profiling, molecular docking, and in vitro anti-hepatocellular carcinoid bioactivity of Suaeda vermiculata extracts
* Hamdoon A. Mohammed a,b, *, Sulaiman A. Almahmoud a , Minhajul Arfeen a ...
Arabian Journal of Chemistry 15, 1-13 2022

MOST CITED SCHOLAR PUBLICATIONS

Therapeutic potential of prodrugs towards targeted drug delivery
AP Mishra, S Chandra, R Tiwari, A Srivastava, G Tiwari
The open medicinal chemistry journal 12, 111 2018
Citations: 42



SYNTHESIS OF NOVEL 2-BENZYLBENZO[d] THIAZOLE-6-SULFONAMIDE DERIVATIVES AS POTENTIAL ANTI INFLAMMATORY AGENT
REENA MAHTAB1 , ASHISH SRIVASTAVA1 , NISHI GUPTA1 , SANDEEP KUMAR KUSHWAHA2 ...
Journal of Chemical and Pharmaceutical Sciences 7 (Issue 1), 34-38 2014
Citations: 26



The Different Kinds of Reaction involved in synthesis of 2-substituted Benzothiazole and its derivatives: A Review
S Jaiswal, AP Mishra, A Srivastava
Res. J. Pharm. Biol. Chem. Sci 3, 631-641 2012
Citations: 20



Phytochemical profiling, molecular docking, and in vitro anti-hepatocellular carcinoid bioactivity of Suaeda vermiculata extracts
* Hamdoon A. Mohammed a,b, *, Sulaiman A. Almahmoud a , Minhajul Arfeen a ...
Arabian Journal of Chemistry 15, 1-13 2022
Citations: 16



Benzothiazole derivative: A review on its pharmacological importance towards synthesis of lead
A Srivastava, AP Mishra, S Chandra, A Bajpai
Int. J. Pharm. Sci. Res 10 (4), 1553-66 2019
Citations: 16



Design, classification, and adverse effects of NSAIDs: A review on recent advancements
MAASASNSS all 6 authorsHamdoon A. Mohammed
Bioorganic & Medicinal Chemistry 112, 1-16 2024
Citations: 13



Formulation development, characterization & estimation of acid neutralization capacity of Shankha Bhasma tablets for the treatment of dyspepsia
A Seth, SK Maurya, A Srivastava
Int J Pharm Pharm Sci 6 (2), 467-9 2014
Citations: 11



Synthesis, characterization, spectroscopic and electrochemical investigation of 2-aminopyridine-3-carboxylic acid copper (II) complexes with diimine
AK Srivastava, K Srivastava, J Prasad
Chemical Data Collections 24, 100272 2019
Citations: 10



Synthesis, Characterization and Evaluation of Ulcerogenic potential for NSAIDs-Alendronate based prodrug
A Srivastava, A Mishra, AK Rai
Research journal of pharmacy and technology 13 (5), 2107-2111 2020
Citations: 7



Physico-chemical and phytochemical evaluation of crude drug powder (leaves) of Polyalthia longifolia
RS Pal, Y Pal, AK Rai, P Wal, A Wal, A Srivastava, S Chandra, ...
Journal of pharmacognosy and phytochemistry 5 (3), 212-213 2016
Citations: 7



Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments
A Wal, P Wal, H Vig, NK Jain, S Rathore, K Krishnan, A Srivastava
Current Drug Discovery Technologies 20 (5), 54-70 2023
Citations: 6



Nsaids-alendronate based prodrug for bone specific drug targeting
A Srivastava, A Mishra, AK Rai
Research Journal of Pharmacy and Technology 13 (7), 3520-3523 2020
Citations: 6



Friedel-Craft reaction: a review
S Prajapati, AP Mishra, A Srivastava
International Journal of Pharmaceutical, Chemical and Biological Sciences 2 2012
Citations: 6



Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
P Wal, H Vig, A Wal, S Rathore, SS Pandey, NK Jain, A Srivastava
Current Aging Science 16 (3), 170-187 2023
Citations: 4



The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review
A Wal, A Srivastava, N Verma, SS Pandey, S Tyagi
Current Pediatric Reviews 20 (1), 66-75 2024
Citations: 3



Role of epigenetic mechanisms in various cancer therapies
R Yadav, A Srivastava, S Chandra, AK Rai
Pharmaceutical and Biological Evaluations 3 (2), 178-184 2016
Citations: 3



A Comprehensive Review on Monkeypox Virus Transmission, Pathogenesis, Treatments and its Preventive Measures
ZN Anil K. Yadav , Ashish Srivastava , Priyanka Verma , Parul Srivastava ...
NeuroQuantology 20 (10), 7320-7335 2022
Citations: 2



The Structure and Mechanism of Spike Protein, as Well as its Role in Numerous Viral Diseases.
P Wal, A Wal, H Vig, A Srivastava, A Kumar
International Journal of Pharmaceutical Investigation 12 (2) 2022
Citations: 2



A Comprehensive Review on the Medicinal Plants for the Treatment of Headache.
A WAL, P WAL, S SHUKLA, A SRIVASTAVA
International Journal of Pharmaceutical Research (09752366) 13 (3) 2021
Citations: 2



A Comprehensive Review of Irritable Bowel Syndrome Screening Models for Drug Research and Development
A Wal, P Wal, N Verma, A Srivastava, AK Rai, S Kosey
Pharmacophore 13 (2-2022), 17-25 2022
Citations: 1